Profile data is unavailable for this security.
About the company
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.
- Revenue in USD (TTM)414.10m
- Net income in USD52.20m
- Incorporated2021
- Employees5.50k
- LocationProcaps Group SA9, rue de BitbourgLUXEMBOURG 1273LuxembourgLUX
- Websitehttps://www.procapsgroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CorMedix Inc | 0.00 | -46.34m | 299.65m | 82.00 | -- | 4.27 | -- | -- | -0.9172 | -0.9172 | 0.00 | 1.28 | 0.00 | 0.00 | -- | 0.00 | -64.32 | -54.84 | -73.33 | -62.32 | -- | 6.18 | -- | -18,323.42 | 6.78 | -- | 0.00 | -- | -100.00 | -- | -56.02 | -- | 46.27 | -- |
| Anavex Life Sciences Corp | 0.00 | -43.16m | 302.17m | 40.00 | -- | 2.23 | -- | -- | -0.5357 | -0.5357 | 0.00 | 1.65 | 0.00 | -- | -- | 0.00 | -29.12 | -40.04 | -31.88 | -43.97 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 0.9857 | -- | -- | -- |
| Acrivon Therapeutics Inc | 0.00 | -60.39m | 303.16m | 58.00 | -- | 1.82 | -- | -- | -2.73 | -2.73 | 0.00 | 5.38 | 0.00 | -- | -- | 0.00 | -37.80 | -- | -40.30 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -93.76 | -- | -- | -- |
| Terns Pharmaceuticals Inc | 0.00 | -90.21m | 303.22m | 66.00 | -- | 1.19 | -- | -- | -1.27 | -1.27 | 0.00 | 3.95 | 0.00 | -- | -- | 0.00 | -32.48 | -41.34 | -33.72 | -45.70 | -- | -- | -- | -31,010.30 | -- | -- | 0.00 | -- | -- | -- | -49.49 | -- | -26.60 | -- |
| XOMA Corp | 4.76m | -46.30m | 303.56m | 13.00 | -- | 3.38 | -- | 63.80 | -4.04 | -4.04 | 0.4148 | 7.72 | -- | -- | -- | 366,000.00 | -- | -4.55 | -- | -4.94 | -- | -- | -858.15 | -31.87 | -- | -- | 0.583 | -- | -21.06 | -2.13 | -105.10 | -- | 23.16 | -- |
| Q32 Bio Inc | 1.16m | -112.96m | 304.20m | 7.00 | -- | 1.13 | -- | 263.15 | -35.17 | -35.17 | 0.3598 | 22.64 | 0.0074 | -- | -- | 165,142.90 | -55.64 | -34.98 | -62.45 | -37.92 | -- | -- | -7,532.87 | -971.76 | -- | -- | 0.00 | -- | -63.97 | -26.32 | -2,156.96 | -- | -60.90 | -- |
| Cerus Corp | 186.80m | -37.49m | 304.56m | 288.00 | -- | 5.78 | -- | 1.63 | -0.2086 | -0.2086 | 1.04 | 0.2905 | 0.8984 | 2.03 | 5.34 | 648,600.70 | -18.11 | -25.99 | -32.81 | -40.62 | 62.54 | 61.90 | -20.15 | -35.81 | 1.55 | -2.91 | 0.5989 | -- | -0.8061 | 19.69 | 12.37 | -- | 32.07 | -- |
| Ventyx Biosciences Inc | 0.00 | -192.96m | 306.35m | 79.00 | -- | 1.06 | -- | -- | -3.29 | -3.29 | 0.00 | 4.12 | 0.00 | -- | -- | 0.00 | -59.46 | -- | -63.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -77.97 | -- | -- | -- |
| Procaps Group SA | 414.10m | 52.20m | 310.27m | 5.50k | 5.28 | 7.88 | 4.45 | 0.7493 | 0.5209 | 0.5209 | 4.16 | 0.3491 | 0.854 | 1.87 | 3.38 | 75,290.18 | 10.77 | -- | 19.01 | -- | 55.04 | -- | 12.61 | -- | 0.9861 | -- | 0.8829 | -- | 0.0434 | -- | 142.18 | -- | -- | -- |
| Lyra Therapeutics Inc | 1.56m | -62.68m | 311.26m | 88.00 | -- | 3.33 | -- | 199.78 | -1.32 | -1.32 | 0.0313 | 1.56 | 0.0123 | -- | -- | 17,704.54 | -49.63 | -58.01 | -57.37 | -68.69 | -- | -- | -4,023.11 | -6,235.31 | -- | -- | 0.00 | -- | 14.31 | 4.60 | -13.39 | -- | 95.14 | -- |
| Nautilus Biotechnology Inc | 0.00 | -63.68m | 311.49m | 167.00 | -- | 1.17 | -- | -- | -0.5103 | -0.5103 | 0.00 | 2.12 | 0.00 | -- | -- | 0.00 | -19.42 | -- | -19.91 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.93 | -- | -- | -- |
| GeneDx Holdings Corp | 202.57m | -175.77m | 312.64m | 1.00k | -- | 1.37 | -- | 1.54 | -7.51 | -7.51 | 8.34 | 8.78 | 0.4454 | 10.03 | 5.40 | 202,566.00 | -38.64 | -- | -49.75 | -- | 44.43 | 11.50 | -86.77 | -121.10 | 2.95 | -- | 0.2425 | -- | -13.69 | 8.72 | 67.98 | -- | 7.77 | -- |
| MeiraGTx Holdings PLC | 14.02m | -84.03m | 313.55m | 419.00 | -- | 2.27 | -- | 22.37 | -1.58 | -1.58 | 0.2483 | 2.17 | 0.0435 | -- | 0.8908 | 33,453.46 | -26.06 | -26.40 | -33.89 | -32.66 | -- | -- | -599.47 | -420.70 | -- | -91.62 | 0.3429 | -- | -11.95 | -- | 35.17 | -- | 12.37 | -- |
| Fractyl Health Inc | 120.00k | -94.27m | 313.60m | 102.00 | -- | -- | -- | 2,613.36 | -1.97 | -1.97 | 0.0025 | -0.7881 | -- | -- | -- | 1,176.47 | -- | -- | -- | -- | 35.83 | -- | -64,242.50 | -- | 3.18 | -2.62 | 3.17 | -- | -- | -- | -48.15 | -- | -- | -- |
| Atea Pharmaceuticals Inc | 0.00 | -135.96m | 313.93m | 75.00 | -- | 0.5606 | -- | -- | -1.63 | -1.63 | 0.00 | 6.65 | 0.00 | -- | -- | 0.00 | -21.55 | -5.90 | -22.46 | -6.98 | -- | -- | -- | -38.91 | -- | -- | 0.00 | -- | -- | -- | -17.30 | -- | -- | -- |
| Petro Usa Inc | 0.00 | -33.38k | 320.21m | -- | -- | -- | -- | -- | -0.0002 | -0.0002 | 0.00 | -0.0008 | 0.00 | -- | -- | -- | -19,074.29 | -192,120.00 | -- | -- | -- | -- | -- | -- | -- | -118.21 | -- | -- | -- | -- | -81.58 | -- | -- | -- |
Data as of Apr 24 2024. Currency figures normalised to Procaps Group SA's reporting currency: US Dollar USD
0.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Credicorp Capital Asset Management SA AGFas of 30 Jun 2023 | 253.55k | 0.23% |
| Exome Asset Management LLCas of 31 Dec 2023 | 126.90k | 0.11% |
| Lemanik Asset Management SAas of 30 Jun 2023 | 101.57k | 0.09% |
| G1 Execution Services LLCas of 31 Dec 2023 | 36.39k | 0.03% |
| UBS Securities LLCas of 31 Dec 2023 | 31.03k | 0.03% |
| Geode Capital Management LLCas of 31 Dec 2023 | 25.39k | 0.02% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 12.24k | 0.01% |
| Activest Wealth Management LLCas of 31 Dec 2023 | 10.00k | 0.01% |
| JPMorgan Asset Management (Europe) SARL (Germany)as of 31 Dec 2023 | 745.00 | 0.00% |
| Pineridge Advisors LLCas of 31 Dec 2023 | 250.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
